ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanner, B.
Right arrow Articles by Zidek, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanner, B.
Right arrow Articles by Zidek, W
Eur Respir J 2000; 16: 648-652
Copyright © ERS Journals Ltd 2000


Original Articles

Platelet function in patients with obstructive sleep apnoea syndrome

BM Sanner, M Konermann, M Tepel, J Groetz, C Mummenhoff, and W Zidek

Patients with obstructive sleep apnoea syndrome (OSAS) are subject to an increased cardiovascular morbidity including myocardial infarction and stroke. Platelets play an important role in the pathogenesis and triggering of acute cardiovascular syndromes. So far, the influence of OSAS on platelet function is not fully understood. Platelet aggregability to epinephrine, collagen, arachidonic acid, and adenosine diphosphate in vitro was measured in 17 consecutive male patients (53.0+/-2.1 yrs) with polysomnographically verified OSAS and compared with that of 15 male controls (50.1+/-3.6 yrs) at 20:00 h, 24:00 h, and 06:00 h. In addition, the long-term effects of continuous positive airway pressure (CPAP) therapy on platelet aggregability was assessed after 6 months. Platelet aggregation in vitro induced by epinephrine showed a slight increase overnight in the untreated OSAS patients (NS) whereas it decreased slightly (NS) in the controls and in the treated OSAS patients. Pretherapeutic platelet aggregability was significantly lowered by CPAP therapy both at 24:00 h (64.0+/-6.5 versus 55.3+/-6.7%, p<0.05) and at 06:00 h (64.1+/-6.5 versus 45.8+/-7.6%; p=0.01). Platelet aggregability during sleep in the controls resembled that found in patients with OSAS during CPAP therapy. The results suggest that obstructive sleep apnoea syndrome contributes, at least in part, to platelet dysfunction and that long-term continuous positive airway pressure treatment may reduce platelet aggregability.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
F. H. Sert Kuniyoshi, A. Garcia-Touchard, A. S. Gami, A. Romero-Corral, C. van der Walt, S. Pusalavidyasagar, T. Kara, S. M. Caples, G. S. Pressman, E. C. Vasquez, et al.
Day-Night Variation of Acute Myocardial Infarction in Obstructive Sleep Apnea
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 343 - 346.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Lopez-Jimenez, F. H. Sert Kuniyoshi, A. Gami, and V. K. Somers
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Chest, March 1, 2008; 133(3): 793 - 804.
[Full Text] [PDF]


Home page
ERRHome page
B. Buyse, J. Hedner, and the participants of working group 2
Sleep apnoea, hypertension and vascular disease: where are we now?
Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Parati, C. Lombardi, and K. Narkiewicz
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1671 - R1683.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. Wolk and V. K. Somers
Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Sleep and the metabolic syndrome
Exp Physiol, January 1, 2007; 92(1): 67 - 78.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. M. O'Brien, L. D. Serpero, R. Tauman, and D. Gozal
Plasma adhesion molecules in children with sleep-disordered breathing.
Chest, April 1, 2006; 129(4): 947 - 953.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Arzt, T. Young, L. Finn, J. B. Skatrud, and T. D. Bradley
Association of Sleep-disordered Breathing and the Occurrence of Stroke
Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1447 - 1451.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Martinez-Garcia, R. Galiano-Blancart, P. Roman-Sanchez, J.-J. Soler-Cataluna, L. Cabero-Salt, and E. Salcedo-Maiques
Continuous Positive Airway Pressure Treatment in Sleep Apnea Prevents New Vascular Events After Ischemic Stroke
Chest, October 1, 2005; 128(4): 2123 - 2129.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. Dunleavy, M. Dooley, D. Cox, and A. Bradford
Chronic intermittent asphyxia increases platelet reactivity in rats
Exp Physiol, May 1, 2005; 90(3): 411 - 416.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. S. Gami, D. E. Howard, E. J. Olson, and V. K. Somers
Day-Night Pattern of Sudden Death in Obstructive Sleep Apnea
N. Engl. J. Med., March 24, 2005; 352(12): 1206 - 1214.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Alonso-Fernandez, F. Garcia-Rio, M. A. Racionero, J. M. Pino, F. Ortuno, I. Martinez, and J. Villamor
Cardiac Rhythm Disturbances and ST-Segment Depression Episodes in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome and Its Mechanisms
Chest, January 1, 2005; 127(1): 15 - 22.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. J. Olson, E. J. Olson, and V. K. Somers
Obstructive Sleep Apnea and Platelet Activation: Another Potential Link Between Sleep-Disordered Breathing and Cardiovascular Disease
Chest, August 1, 2004; 126(2): 339 - 341.
[Full Text] [PDF]


Home page
Eur Heart JHome page
O. Milleron, R. Pilliere, A. Foucher, F. de Roquefeuil, P. Aegerter, G. Jondeau, B. G Raffestin, and O. Dubourg
Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study
Eur. Heart J., May 1, 2004; 25(9): 728 - 734.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. S. Hui, F. W. Ko, J. P. Fok, M. C. Chan, T. S. Li, B. Tomlinson, and G. Cheng
The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome
Chest, May 1, 2004; 125(5): 1768 - 1775.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G J Gibson
Sleep disordered breathing and the outcome of stroke
Thorax, May 1, 2004; 59(5): 361 - 363.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. Javaheri, W. T. Abraham, C. Brown, H. Nishiyama, R. Giesting, and L. E. Wagoner
Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation
Eur. Heart J., February 1, 2004; 25(3): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. von Kanel and J. E. Dimsdale
Hemostatic Alterations in Patients With Obstructive Sleep Apnea and the Implications for Cardiovascular Disease
Chest, November 1, 2003; 124(5): 1956 - 1967.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. S. M. Shamsuzzaman, B. J. Gersh, and V. K. Somers
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
JAMA, October 8, 2003; 290(14): 1906 - 1914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. M. Kahler, J. Wechselberger, C. Molnar, C. Prior, R. Schulz, W. Seeger, and F. Grimminger
Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia
Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 92 - 93.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. S. T. LEUNG and T. DOUGLAS BRADLEY
Sleep Apnea and Cardiovascular Disease
Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.